Skip to main content

Table 1 The clinicopathological features in all cohorts

From: The feasibility of proteomics sequencing based immune-related prognostic signature for predicting clinical outcomes of bladder cancer patients

Clinical characteristics

TCGA cohort (n = 405)

E-MTAB-4321 cohort (n = 476)

General cohort (n = 129)

Age

69 (34 ~ 90)

69 (24 ~ 96)

67 (47 ~ 89)

Gender

 Female

106

109

20

 Male

299

367

109

Stage

 I

2

460

0

 II

129

16

76

 III

139

0

53

 IV

133

0

0

 Unknown

2

0

0

T

 Ta

0

345

0

 Cis

0

3

0

 T1

3

112

0

 T2

118

16

77

 T3

192

0

27

 T4

58

0

25

 Unknown

34

0

0

N

 N0

235

/

122

 N1

46

/

5

 N2

75

/

1

 N3

7

/

1

 Unknown

42

/

0

M

 M0

195

/

129

 M1

11

/

0

 Unknown

199

/

0